UPST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
UPST is not a clear buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock has some constructive momentum and decent option sentiment, but the analyst community has been cutting targets, the latest quarter was mixed, and there is no strong proprietary buy signal. Since the user is impatient and does not want to wait for a better entry, my direct view is to hold off on buying and wait for a cleaner setup.
UPST is in a short-term uptrend with MACD histogram positive and expanding, which supports bullish momentum. However, RSI_6 at 77.879 suggests the stock is stretched after recent strength, and moving averages are converging rather than showing a powerful long-term breakout structure. Price is trading near resistance at 33.205 with the current price at 32.79, while pivot support is 30.317. That means upside exists, but the current entry is not ideal for a long-term beginner investor. The recent pattern-based outlook is also mixed, with only modest near-term upside and a weak one-month profile.
BTIG upgraded the stock to Buy and highlighted lower funding risk from the bank charter application, which could be a meaningful catalyst if progress continues. Options sentiment is also mildly bullish.
The analyst trend is clearly negative on price targets, with multiple firms lowering targets in early May. Q1 results were mixed: revenue beat expectations, but profitability and adjusted EBITDA/margins missed, forcing expectations for a second-half ramp. There is also a class action lawsuit headline, which adds overhang. Technicals show the stock is already extended, and the pattern-based forecast does not show compelling medium-term upside. No AI Stock Picker or SwingMax signal is present today.
Latest quarter shown in the analyst commentary was Q1 2026, and it was mixed. Revenue came in above expectations, but margin and adjusted EBITDA missed. Truist noted Q1 margin of 13% versus a FY26 target of 21%, implying a strong sequential improvement is needed later in the year. Management reportedly kept FY26 revenue and adjusted EBITDA guidance intact and expects both to be weighted toward the second half of 2026. The provided news also highlights strong FY2025 revenue growth of 58.9%, which supports the long-term growth case, but current profitability quality remains uneven.
Wall Street is mixed but leaning cautious. Positive views remain from Mizuho, Truist, Needham, Piper Sandler, and BTIG, but price targets have been cut across the board, including from Mizuho, Morgan Stanley, Truist, Needham, Piper Sandler, BofA, and Mizuho again. The bullish case is that revenue growth remains strong, funding risk may be easing, and valuation could recover if bank charter progress materializes. The bearish case is that margins and EBITDA are not yet consistently delivering, targets are being reduced, and macro uncertainty is pressuring sentiment. Overall, the pros see a recoverable growth story, while the cons see execution and profitability risk.
